Abstract
The development of serotonin receptor knockout mice has provided an opportunity to study antidepressant drug effects in animals with targeted genetic deletion of receptors involved in antidepressant responses. In the current study, the effects of two types of antidepressant drugs, the selective serotonin reuptake inhibitors fluoxetine and paroxetine and the selective norepinephrine reuptake inhibitor desipramine, were examined in 5-hydroxytryptamine (5-HT)1A and 5-HT1B receptor mutant mice using the tail suspension test (TST). Under baseline conditions, the immobility of 5-HT1A receptor mutant mice, but not 5-HT1B receptor mutant mice, was significantly lower than that of wild-type mice. The decreased baseline immobility in 5-HT1A receptor mutant mice was reversed by pretreatment with α-methyl-para-tyrosine, but not bypara-chlorophenylalanine, suggesting mediation by enhanced catecholamine function. In wild-type mice, fluoxetine (10.0–20.0 mg/kg i.p.) and desipramine (5.0–20.0 mg/kg i.p.) both significantly decreased immobility in the TST. In 5-HT1Areceptor mutant mice, desipramine (20.0 mg/kg i.p.) significantly decreased immobility, whereas fluoxetine (20.0 mg/kg i.p.) and paroxetine (20.0 mg/kg i.p.) had no effect. The immobility of 5-HT1B receptor mutant mice was decreased similarly by desipramine (5.0–20.0 mg/kg i.p.). However, the effect of low doses of fluoxetine were significantly augmented in the 5-HT1Breceptor mutant mice (2.5–20.0 mg/kg i.p.) compared with wild-type mice. Administration of selective 5-HT receptor antagonists in wild-type mice partially reproduced the phenotypes of the mutant mice. These results suggest that 5-HT1A and 5-HT1Breceptors have different roles in the modulation of the response to antidepressant drugs in the TST.
Footnotes
-
This research was supported by U.S. Public Health Service Grant P01-MH 48125.
- Abbreviations:
- 5-HT
- serotonin or 5-hydroxytryptamine
- SSRI
- selective serotonin reuptake inhibitor
- NE
- norepinephrine
- FST
- forced swimming test
- TST
- tail suspension test
- PCPA
- para-chlorophenylalanine
- AMPT
- α-methyl-para-tyrosine
- DA
- dopamine
- DOPAC
- 3,4-dihydrophenylacetic acid
- 5-HIAA
- 5-hydroxyindoleacetic acid
- ANOVA
- analysis of variance
- Received February 12, 2001.
- Accepted May 26, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|